ND UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND (EUR HEDGED) I-B-DIST | 29/12 | · |
| ND UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND (EUR HEDGED) K-1-ACC | 29/12 | · |
| ND UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND (EUR HEDGED) P-ACC | 29/12 | · |
| ND UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND (EUR HEDGED) Q-ACC | 29/12 | · |
| ND UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND I-A1-ACC | 29/12 | · |
| ND UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND I-A2-ACC | 29/12 | · |
| ND UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND I-B-ACC | 29/12 | · |
| ND UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND I-B-DIST | 29/12 | · |
| ND UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND K-1-ACC | 29/12 | · |
| ND UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND K-1-DIST | 29/12 | · |
| ND UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND P-ACC | 29/12 | · |
| ND UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND Q-ACC | 29/12 | · |
| ND UBS (LUX) EQUITY FUND - BIOTECH (USD) (EUR) Q-ACC | 30/12 | 20,87% |
| ** UBS (LUX) EQUITY FUND - BIOTECH (USD) P-ACC | 30/12 | 20,02% |
| ** UBS (LUX) EQUITY FUND - BIOTECH (USD) Q-ACC | 30/12 | 21,25% |
| ** UBS (LUX) EQUITY FUND - BIOTECH (USD) QL-ACC | 30/12 | 21,50% |
| ** UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR HEDGED) P-ACC | 30/12 | 26,10% |
| *** UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR HEDGED) Q-ACC | 30/12 | 27,54% |
| ** UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR) I-A1-ACC | 30/12 | 15,56% |
| * UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR) P-ACC | 30/12 | 14,21% |
